The melanoma treatment market is projected to grow at the CAGR of 12.62% during the forecast period to reach a total market size of US$5.910 billion in 2023 from US$2.896 billion in 2017. Melanoma is a type of skin cancer that develops in the melanocyte cells that are responsible for producing melanin, the pigment that imparts colour to the skin. It occurs when unrepaired damage to skin cells leads to their rapid multiplication, thus forming malignant tumours. The primary cause of Melanoma is prolonged exposure to ultraviolet light. If detected and treated at an early stage, the disease is almost always curable. In recent years, there has been a rise in the number of new cases reported, due to changing environmental landscape. The market for its treatment has thus witnessed significant growth. The United States in North America and Australia and New Zealand in Oceania are the largest markets for Melanoma treatment given the extremely high prevalence and robust medical research in these regions.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the Melanoma Treatment value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are AstraZeneca, Novartis AG, Merck & Co. Inc. and Bristol-Myers Squibb among others.
Segmentation
The melanoma treatment market has been analysed through following segments:
By Type
Cutaneous Melanoma
Ocular Melanoma
Mucosal Melanoma
By Therapy
Surgery
Immunotherapy
Targeted Therapy
Chemotherapy
Radiation Therapy
By Geography
North America
United States
Canada
Mexico
Others
South America
Brazil
Argentina
Others
Europe
Germany
France
Italy
Spain
UK
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
India
China
Japan
Australia
Others
.jpg)
